Skip to main content
TipRanks
Go Ultimate75% OFF

Robert Zimmer Insider Profile

4 Followers

Robert Zimmer, President & Chief Science Officer, Ten Percent Owner at ImmuPharma, holds 27.34M shares in ImmuPharma (Ticker: GB:IMM). Most recently, Robert Zimmer Bought 2,000,000 shares of ImmuPharma on Mar 30, 2020 for an estimated value of 200.00K .

Robert Zimmer's Trading History

IMM
ImmuPharma
Mar 30, 2020President & Chief Science Officer, Ten Percent OwnerInformative Buy200.00K£710.96K
GB:IMM
Insider Shares: 27.34M (1494.15%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Mar 30, 2020Informative Buy£200.00K2,000,000£10.00-14.30%―
Feb 05, 2016Informative Buy£320.00K1,230,769£26.00+115.60%―

You May Also Like

Robert Zimmer insider profile FAQ

What is the percentage of profitable transactions made by Robert Zimmer?
The percentage of profitable transactions made by Robert Zimmer is 50%.
What is the average return per transaction made by Robert Zimmer?
The average return per transaction made by Robert Zimmer is 50.60%.
What stocks does Robert Zimmer hold?
Robert Zimmer holds: GB:IMM stocks.
What was Robert Zimmer’s latest transaction?
Robert Zimmer’s latest transaction was an Informative Buy of 200.00K .
What was Robert Zimmer's most profitable transaction?
Robert Zimmer’s most profitable transaction was an Informative Buy of GB:IMM stock on February 5, 2016. The return on the trade was 115.60%.
What is Robert Zimmer's role in ImmuPharma?
Robert Zimmer's role in ImmuPharma is President & Chief Science Officer, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.